comparemela.com

Latest Breaking News On - Pamela keck - Page 3 : comparemela.com

Medigene AG Expands Patent Portfolio with European Patent Grant for its NY-ESO-1 – targeted T Cell Receptor

Planegg/Martinsried, May 2, 2024. Medigene AG , an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, announces today that the.

Medigene AG reports Financial Results and Business Update for Q1 2024

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.